ALZN

Conviction 49HealthcareScan · Mon, Aug 10, 2026

ALZN$1.37-0.72%

ResistanceSupportVol 14Insider buy

Vol MA14 47.29K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Alzamend Neuro, Inc.PHARMACEUTICAL PREPARATIONSwww.alzamend.com ↗

Price1.37

Change-0.72%

Gap+0.00%

Rel volume0.32×

Avg volume52.51K

Avg $ vol68.86K

SMA 201.31

SMA 501.24

SMA 2001.68

Price vs 50+10.65%

Price vs 200-18.63%

MA stackmixed

50/200 cross—

Supertrendup · 1.13

RSI (14)57

MACD hist0.01

MACD cross—

Stoch %K / %D67 / 78

ADX (14)44

+DI / −DI18 / 7

RSI divergence—

MACD divergenceBearish

ATR %+7.08%

ADR %7.78%

52w high2.62

52w low0.8575

From 52w high-47.71%

Above 52w low+59.77%

New 52w highNo

SqueezeOff

Bollinger width22.76%

%B0.71

Donchian pos76.47%

Donchian high1.45

Donchian low1.11

AVWAP (52w high)1.58

vs AVWAP high-13.30%

AVWAP (52w low)1.18

vs AVWAP low+16.38%

OBV trendUp

Chaikin MF (20)0.42

Today vs 20d0.32×

Avg vol (14d)47.29K

Avg vol (20d)52.51K

Avg $ vol (20d)68.86K

Market cap6.56M

RS 3m (vs SPY)+23.55%

RS 6m (vs SPY)-40.85%

RS line new highNo

Trend template3/8

Technical rank37.5

1 week+4.58%

1 month+18.10%

3 months+29.25%

6 months-26.74%

1 year-39.65%

YTD-27.89%

P/E-0.75

P/B8.95

P/S—

P/FCF—

EPS-2.63

Div yield—

ROE—

ROA-421.88%

Debt/Eq—

Current0.46

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-94.30%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.85M

Revenue—

Net income-2.2M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.8M

Employees7

ListedTue, Jun 15, 2021

Free float3.75M

Float %98.6%

Short interest328.29K

Days to cover1.1d

Short volume85.2%

Squeeze score43 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank37.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.45

Support1.08

Days since event—

Candle confirm—

News sentiment—

Financials as of Sat, Jan 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALZN

All disclosures →

No recent disclosed trades by Congress in ALZN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALZN · 1 buy

Insider	Side	Shares	Value	Traded	Filed
AULT MILTON C III Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16
AULT MILTON C III Director · Common Stock · 2026-04-14	Buy	108.39K	$109K	2026-04-14	2026-04-16

SEC filings

EDGAR filings in ALZN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.